Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
About Health Canada
Access to Information Requests Completed - March 2011
This content was archived on June 24, 2013.
Archived Content
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)
If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.
Acronyms and Descriptions
- AER
- Adverse Reaction Report (Adverse Event)
- AIDS
- Acquired Immune Deficiency Syndrome
- ATI
- Access to Information
- CCRPB
- Consumer and Clinical Radiation Protection Bureau
- CHVI
- Canadian HIV Vaccine Initiative
- CIHR
- Canadian Institutes of Health Research
- DIN
- Drug Identification Number
- FNIHB
- First Nations and Inuit Health Branch
- GIS
- Geographic information system
- GMP
- Good Manufacturing Practices
- HICPS
- Health Information and Claims Processing Services
- HIV
- Human Immunodeficiency Virus
- HPFB
- Health Products and Food Branch
- MMA
- Methyl methacrylate
- NPN
- Natural Product Number
- PMRA
- Pest Management Regulatory Agency
- RFP
- Request for proposal
- SAE
- Serious adverse event
- SAP
- Special Authorization Program
- SPB
- Strategic Policy Branch
- SPF
- Sun Protection Factor
- TBIPS
- Task-Based Informatics Professional Services
Completed Requests
| Request # | Request text summary | Status of Completed Request |
|---|---|---|
| A-2008-00249 | All briefing notes and reports to the Minister on all potential risks/threats of pandemic and Canada's level of preparation. (Jan 1, 2007 to Jun 12, 2008). | Disclosed in part |
| A-2008-00390 | Information regarding the product Oxeze Turbuhaler (formoterol fumarate dehydrate), DINs 02237224 and 02237225 by AstraZeneca Canada Inc. | Disclosed in part |
| A-2008-00785 | All information generated by the department and minister's office regarding funding for community AIDS programs. (Feb 1, 2007 and Nov 1, 2008). | Disclosed in part |
| A-2008-00870 | 2008 records on the strategies developed, underway, completed with a timetable of projects, and their costs as they relate to reviewing the data on the health risks and other factors associated with chrysolite asbestos. | Disclosed in part |
| A-2008-00954 | Contract deliverables where available for (All contract numbers start with 4500): Pollution Probe 193070: Toxicolgy Advice 194020: Philip Nicolson 192866: Stonecircle 191147: Richard Labelle 191465: Clean Air Foundation 191320: Niva 191780: Davidson-Greenwood 189648: Tazeen Rahman 192026: Tox-Ecology 189492, 189500, 189495, 189498: Research Power 189372: Global Tox 189902: Gord Alluck 192057: Tazem Virani 187741: Lenord Ritter 187990: Richard Saugnessy 185416: Neejan Burnside 187290: Sebastain Kavalaski 184819: Elaine Gaudet 185235: Richard Labelle 184919: Gerry Steele 183866: Low Edwars 179356: Doner Willies 179055: Diane Bockier 180407: Brian Skidman 182184: Slyvia Morawetz 182144: Bim Larsson 179909; Tina-Marie Christain 179911; Deloitte 189845, 180936, 180744, 177872; Sussex circle 180122, 178478. |
Disclosed in part |
| A-2008-00956 | All 2008 and 2009 records relating to any research and actions on the specific substances on the proposed priority list for indoor air pollutants as well as any follow-ups to the March 2008 Healthy Indoors Partnership consultations report. | Disclosed in part |
| A-2008-01032 | All records about a retailer's decision to pull "Sophie the Giraffe/Sophie la Giraffe" from store shelves, citing a health hazard (choking hazard), and any records about Health Canada's review of the product or complaints filed about the product. (Sep 1, 2008 to Feb 17, 2009). | Disclosed in part |
| A-2008-01126 | Copy of a list of all ministerial correspondence for the Minister. (Jan 1, 2009 to Mar 24, 2009). | Disclosed in part |
| A-2009-00109 | All emails correspondence in the Safe Environments Programme, Healthy Environments and Consumer Safety Branch, Deputy Minister's Office, and Communication/Media Relations department related to the release to the media and/or public of the Expert Panel on Chrysotile Asbestos. (Mar 18, 2008 to Apr 18, 2009). | Disclosed in part |
| A-2009-00279 | All documentation relating to the possibility as a supervised injection site opening in Quebec. | Disclosed in part |
| A-2009-00421 | All documents related to the evaluation of ESI Canada's proposal or bid for the HICPS contract during the competitive RFP that closed in 2007. | Disclosed in part |
| A-2009-00424 | All documents that led to the decision to award the contract, as the claims processor for the Health Canada Non-Insured Health Benefits Program, to ESI Canada. | Disclosed in part |
| A-2009-00523 | All records about the recall of Simplicity cribs in the USA and in Canada, distributed by Elfe Juvenile Products. (Jul 2, 2009 to Jul 20, 2009). | Disclosed in part |
| A-2009-00700 | Location of Health Canada/Prairie Plant Systems Inc. cannabis production facility since moved from Flin Flon, and evidence of GMP compliance at new production facility | All exempted |
| A-2009-00974 | All records in the control of Health Canada in any medium that were created to brief Health Minister Leona Aglukkaq regarding the H1N1 influenza virus. Nov 1, 2009 to Nov18, 2009 | All disclosed |
| A-2009-01190 | A copy of the weekly list of First Nations and other (Municipal, Inuit) on drinking water advisories. (January 2001 to Jan 19, 2010). | All disclosed |
| A-2009-01208 | All information from Inspection number 1075912 and including lab test results performed on the socks in question Reference #51009723. | Disclosed in part |
| A-2009-01272 | Provide the document 2005-10-03 Confirmation of Report of SAE Report 50330, related to a clinical trial sponsored by Genpharm and conducted by Anapharm. | Disclosed in part |
| A-2009-01273 | Provide the report 2005-10-13 SAE Report 50330, related to a clinical trial sponsored by Genpharm and conducted by Anapharm. | Disclosed in part |
| A-2009-01274 | Provide the document 2005-12-06 50330 adverse event correction related to a clinical trial sponsored by Genpharm and conducted by Anapharm. | Disclosed in part |
| A-2009-01275 | Provide the document 2005-12-07 50330 adverse event correction related to a clinical trial sponsored by Genpharm and conducted by Anapham. | All exempted |
| A-2009-01337 | All records relating to the following company and product(s): - Innovation Ventures LLC, doing business as Living Essentials - Chaser Energy Drink - Chaser 5 Hour Energy Drink - 5 Hour Energy Drink - 5 Hour Energy |
Disclosed in part |
| A-2009-01450 | Information regarding the product Terre-Mermc, NPN 02237906, by Bio Actifs Inc. | Disclosed in part |
| A-2010-00030 | Information regarding the product CANESORAL, DIN 02311690 by Bayer Inc. | All disclosed |
| A-2010-00061 | Response to RFP #H3531-1000089273 Issued May 20-08 by Saskatchewan Regional Office - First Nations and Inuit Health; Call for a medical Health Consultant. | All exempted |
| A-2010-00085 | All correspondence and reports created/generated, such as causality assessments, benefit-risk assessments, and signal assessments and periodic safety update reports assessments, pertaining to the product Percocet. (Jan 1, 1996 to May 27, 2010). | All disclosed |
| A-2010-00088 | All correspondence and reports created/generated, such as causality assessments, benefit-risk assessments, signal assessments and periodic safety update reports assessments, pertaining to the product TYLENOL 3. (Jan 1, 1996 to May 27, 2010). | Disclosed in part |
| A-2010-00102 | Information regarding the product Colgate Sensitive Pro-Relief, NPN 80017891. | Disclosed in part |
| A-2010-00118 | Information regarding Galderma - Cetaphil Restoraderm Eczema Moisturizing Lotion. | Disclosed in part |
| A-2010-00119 | Information regarding Galderma - Cetaphil Restoraderm Eczema Moisturizing Wash. | Disclosed in part |
| A-2010-00150 | Information regarding the product Cough & Cold, DIN 02328380 by ACCUDIAL PHARMACEUTICAL INC. | Disclosed in part |
| A-2010-00165 | Information regarding multiple births resulting from assisted-reproduction procedures. (Jan 1, 2009 to May 7, 2010). | Disclosed in part |
| A-2010-00241 | Email/communication between Art Murphy and Carolina Giliberti regarding: IICHI (International Indigenous Centre for Health Intelligence), Alberta First Nations Epicentre, epicentre, GIS, ESRI, Okaki Health Intelligence, Okaki, Wei Tam, Tom Vlasschaert, Malik Agyemang, Omolade Saliu, Erik Ellehoj, Salim Samamani, Michael Semenchuk, Derek Fearnly, Edward Wu, Luxous, or BITS. | Disclosed in part |
| A-2010-00255 | Question Period notes. March 1-26, 2010: - Safety and Security Incidents at the National Microbiology Laboratory - Medical Isotopes Compensation for Costs (HPFB) - HIV Cases Surge 20% in Manitoba (FNIHB) - Cross-Border Drug Sales (SPB) - Research Accountability (CIHR) - Fetal Alcohol Spectrum Disorder in First Nations Communities (FNIHB) - Medical Isotopes Compensation for Costs (HPFB) - Supply of Medical Isotopes (HPFB) - Nursing Shortages (SPB) - Supply of Medical Isotopes (HPFB) - Medical Isotopes Compensation for Costs (HPFB) - Thallium Supply (HPFB) - Wait Times (SPB) - Supply of Medical Isotopes (HPFB) |
Disclosed in part |
| A-2010-00259 | All documents regarding to the pricing and the availability of the drug known as lamivudine (also sold under the brand names 3TC, Heptovir, Combivir (a combination of zidovudine and lamivudine) and Trivizir (a combination of zidovudine, lamivudine and abacavir)). From 1989 to 2004. | Disclosed in part |
| A-2010-00299 | Request for a Standing Offer, Fit Mask Testing, Solicitation Number: H3601-090509/A. | Disclosed in part |
| A-2010-00320 | Request for Standing Offer. Health Canada, 0451 Nursing Services, Reference Number: 4500231184, Contract Period: 2010-03-15 to 2010-03-29. | Disclosed in part |
| A-2010-00326 | A list of persons and corporations who have been granted an exemption under either s.67 or s.56 of the Controlled Drugs Substances Act or have been granted a dealer licence, under the Narcotics Control Regulations, for the purpose of manufacturing cannabis sativa. | Disclosed in part |
| A-2010-00397 | AERs for the products Trophic Canada, Trophic, Wild Rose by Trophic Canada Ltd. | Disclosed in part |
| A-2010-00402 | All records, of incidents suspected of contravening the Canada Health Act,related to: Charges for abortion services in Prince Edward Island and New Brunswick. | Disclosed in part |
| A-2010-00403 | All records, of incidents suspected of contravening the Canada Health Act,related to: Charges to patients for diagnostic services by private clinics. | Disclosed in part |
| A-2010-00404 | All records, of incidents suspected of contravening the Canada Health Act,related to: Out-of-country portability. | Disclosed in part |
| A-2010-00405 | All records, of incidents suspected of contravening the Canada Health Act,related to: Out-of-province portability in regards to Quebec non-payment of host province rate for medically necessary physician services. | Disclosed in part |
| A-2010-00406 | All records, of incidents suspected of contravening the Canada Health Act,related to: Alberta Crown's Right of Recovery Act charges to patients by private primary health clinics. | Disclosed in part |
| A-2010-00407 | All records, of incidents suspected of contravening the Canada Health Act,related to: Charges to British Columbia and Quebec residents for surgical services received in private clinics. | Disclosed in part |
| A-2010-00441 | Information regarding the product XP-828L;Dermylex, NPN 80016359 by Advitech Inc. | Disclosed in part |
| A-2010-00444 | Information regarding the product Probaclac A, NPN 80013765 by Les Laboratoires Nicar Inc. | Disclosed in part |
| A-2010-00447 | Information regarding the product Probiotic Factors Capsules Fos Free, NPN 02242087 by Future Formulations Inc. | Disclosed in part |
| A-2010-00448 | Information regarding the product Probiotic Factors Capsules, NPN 02242088 by Future Formulations Inc. | Disclosed in part |
| A-2010-00450 | Information regarding the product Maximum Acidophilus Probiotic, NPN 80011200 by Vitaminol Inc. | Disclosed in part |
| A-2010-00467 | All food preparation inspection reports produced by Health Canada as part of its Flight Kitchen Food Safety Audit Program. (Sep 1, 2009 to Jul 13, 2010) | Disclosed in part |
| A-2010-00470 | A copy of the most recent inspection report for all restaurants and food-service companies operating at Vancouver airport. | Disclosed in part |
| A-2010-00472 | Information regarding the product APO-TRAMADOL/ACET, DIN 02336790 by APOTEX INCORPORATED. | Disclosed in part |
| A-2010-00491 | All records from tobacco manufacturers and/or their representatives concerning possible changes to health warnings and/or other packaging and labelling requirements for tobacco products. (Nov 1, 2009 to Jul 20, 2010). | All disclosed |
| A-2010-00492 | All records from the tobacco industry and/or their representatives concerning possible changes to health warnings and/or other packaging and labelling requirements for tobacco products. (Nov 1, 2009 to Jul 20, 2010). | All disclosed |
| A-2010-00514 | Information regarding the product Micro-K Extencaps®, NPN 02042304 by Paladin Labs Inc. | Disclosed in part |
| A-2010-00519 | Documents concerning the safety situation of Health Canada employees in Pikangikum. (Aug 11, 2009 to Aug 11, 2010). | Disclosed in part |
| A-2010-00541 | Obtain a full copy of all documents listing the number of employees who work for Health Canada (January 1, 1990 to July 28, 2010). | All disclosed |
| A-2010-00622 | Any information regarding Correctional Service Canada Warkworth Institution, located in Campbellford, Ontario for the site and surrounding area regarding environmental issues and human health issues. | All disclosed |
| A-2010-00658 | Final report titled 'Case Study of Canada's Food Guide for the Summative Evaluation of the Office of Nutrition Policy and Promotion Program'. Contract for this report published January 15, 2010 on the Merx.com website, solicitation number: 1000110471. | All disclosed |
| A-2010-00710 | AERs for the product Diamicron NOS. Report numbers: 000313488 (linked to: 000322470 & 000322540), 000221199 and 000217153. | Disclosed in part |
| A-2010-00711 | AERs for the product Diamicron MR. Report numbers: 000217516, 000304826 and 000337597. | Disclosed in part |
| A-2010-00714 | Results from a study about the use of medical marijuana in Canada. The time frame 2003 and/or 2006-2007. | All disclosed |
| A-2010-00720 | Information regarding the number of citizens with valid authorization to possess marijuana for medical purposes and a valid production licence for personal use. | All disclosed |
| A-2010-00729 | All documents, including those by pesticide manufacturers and the general public, to PMRA relating to the drafting of paragraph 17.7(2)(d) of the Pest Control Products Regulations. | Disclosed in part |
| A-2010-00743 | AERs for the product Canesoral. Report numbers: 000344409 and 000345175. | Disclosed in part |
| A-2010-00744 | Records of complaints by consumers who suspect MMA is being used in salons and results of the investigation. | Disclosed in part |
| A-2010-00764 | Information regarding the product APO-CICLOPIROX, DIN 02298953 by APOTEX INCORPORATED. | Disclosed in part |
| A-2010-00769 | Any briefing notes/speaking notes to the Ministers' Office in preparation/contemplation of any meeting with third party stakeholders including, but not limited to: Physicians for a Smoke Free Canada, Canadian Cancer Society, Canadian Lung Association; and any Tobacco Product Manufacturers. (Feb 1, 2010 to Oct 12, 2010). | Disclosed in part |
| A-2010-00797 | Emails to/from the Marihuana Medical Access Division to/from the Health Minister Leona Aglukkaq and staff regarding approving medical marijuana licences and renewals. (Jan 1, 2009 to Dec 31, 2009). | Disclosed in part |
| A-2010-00854 | Information regarding the product Genestra Brands Super Neurogen Dha, NPN 80005871 by Seroyal International. | Disclosed in part |
| A-2010-00858 | All emails to and from Dr. Robin Marles about energy drinks. (Sep 1, 2010 to Nov 8, 2010). | Disclosed in part |
| A-2010-00875 | All records that analyse or comment on the public opinion research study The Health Effects of Tobacco and Health Warning Messages on Cigarette Packages Survey of Adults and Adult Smokers. (Jan 1, 2008 to Sep 1, 2010). | Disclosed in part |
| A-2010-00891 | A list of all contracts and contractual documents for insurance and risk management. (Oct 1, 2006 to Nov 22, 2010). | Disclosed in part |
| A-2010-00894 | Previously released request A-2009-01121: All documents concerning the number of cell phones purchased by your institution and the costs related to the use of these telephones (January 1, 2000 to December 31, 2007). | All disclosed |
| A-2010-00896 | Question Period Notes: - Medical Isotopes Compensation to Provinces (Sep 16, 2010) - Bottled Water (Sep 24, 2010) |
Disclosed in part |
| A-2010-00897 | Question Period Notes of Sep 8, 2010: - Asbestos - Chrysotile - Consumer Safety - WiFi Systems - Flavoured Cigars and Cigarillos - Food Safety - Hepatitis C Compensation - Lead in Children's Jewellery - Mental Illness - Cost of Disability |
All disclosed |
| A-2010-00900 | Breakdown of program components and costs of the Health Canada's work on cigarette warning labels. | Disclosed in part |
| A-2010-00903 | All records related to consideration by the Food and Drug Administration (within the Department of Health and Human Services of the United States of America) to use image of Barb Tarbox as health warnings on cigarette packages in the USA. (Sep 1, 2010 to Nov 17, 2010). | Disclosed in part |
| A-2010-00907 | A list of all briefing notes created or sent to the Minister of Health from November 1 to 20, 2010. | Disclosed in part |
| A-2010-00908 | All records created to brief Health Minister Leona Aglukkaq for her November 22, 2010 meeting with the Director of the Office of National Drug Control Policy (ONDCP) USA. | Disclosed in part |
| A-2010-00915 | Information regarding the medical device Ultrasound Massager, Licence No. 71511 by Skylark Device & Systems Co. Ltd. | All disclosed |
| A-2010-00944 | Ministerial briefing materials prepared for the Minister of Health on the subject of the CHVI initiative in 2010. | All disclosed |
| A-2010-00945 | AERs. Report numbers: 000320928, 000331207, 000332125, 000332388, 000332816, 000332952, 000333217, 000333531, 000333728, 000333729, 000333905, 000333945, 000334090, 000334094, 000335218 and 000335227. | Disclosed in part |
| A-2010-00946 | AERs. Report numbers: 000209957, 000223343, 000315559, and 000326634. | Disclosed in part |
| A-2010-00958 | Records to Heath Minister Leona Aglukkaq discussing Radon in the House of Commons. (Sep 15, 2010 to Dec 10, 2010). | Disclosed in part |
| A-2010-00971 | Information regarding the product NIASPAN FCT by Oryx Pharmaceuticals Inc. | Disclosed in part |
| A-2010-00972 | Information regarding the product NIASPAN by Oryx Pharmaceuticals Inc. | Disclosed in part |
| A-2010-00978 | On January 22, 2008, Stryker Canada issued a recall of Trident and Trident PSL hemispherical capsules for hip prostheses. Information regarding serious or unforeseen negative side effects reported by patients who received one of these prostheses. | Disclosed in part |
| A-2010-00982 | A list of contract deliverables relating to health issues including, but are not limited to, environmental contaminants such as radon, the testing of tap water, the dust study, the study of the presence of arsenic. (Jan 1, 2008 to Dec 15, 2010). | All disclosed |
| A-2010-00989 | AERs for the product WINRHO SDF by Cangene Corporation. Report numbers: 000220227, 000220343, 000223049, 000223792, 000300771, 000300797, 000303243, 000309300, 000311071, 000315436, 000321361, 000323090, 000332509 and 000312396. | Disclosed in part |
| A-2010-01011 | Information regarding the product Remodulin, DINs 02246552, 02246553, 02246554, and 02246555 by United Therapeutics Corporation. | Disclosed in part |
| A-2010-01034 | All documents regarding Health Canada's policies on computer and Internet use, including any reports of violations or abuses and any resulting actions. (Jan 1, 2010 to Jan 6, 2011). | All disclosed |
| A-2010-01035 | Information regarding the product OSTOFORTE, DIN 00009830 by Merck Frosst. | All disclosed |
| A-2010-01036 | Information regarding the product D-FORTE, DIN 02237450 by Euro-Pharm International Canada Inc. | Disclosed in part |
| A-2010-01056 | Information regarding the product Vitalux Plus Omega 3, NPN 80016683 by Novartis. | Disclosed in part |
| A-2010-01067 | All documents under the control of Health Canada from London Health Sciences Centre on the narcotic Fentanyl missing from its inventory at University Hospital in London, Ontario in 2010. | Disclosed in part |
| A-2010-01076 | All processing records relating to ATI file number A-2009-00294. | Disclosed in part |
| A-2010-01082 | AERs for the product BETASERON. Report numbers: 000352870 and 000353637. | Disclosed in part |
| A-2010-01090 | Report of losses and thefts of codeine. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01099 | AER. Report number: 000308365. | Disclosed in part |
| A-2010-01100 | AER. Report number: 000308298. | All disclosed |
| A-2010-01101 | AER. Report number: 000308306. | All disclosed |
| A-2010-01102 | AER. Report number: 000308309. | All disclosed |
| A-2010-01103 | AER. Report number: 000308307. | Disclosed in part |
| A-2010-01104 | AER. Report number: 000308299. | All disclosed |
| A-2010-01105 | AER. Report number: 000308301. | All disclosed |
| A-2010-01106 | AER. Report number: 000308303. | All disclosed |
| A-2010-01107 | AER. Report number: 000308305. | All disclosed |
| A-2010-01108 | AER. Report number: 000308296. | All disclosed |
| A-2010-01110 | AER. Report number: 000308314. | All disclosed |
| A-2010-01111 | AER. Report number: 000308315. | All disclosed |
| A-2010-01112 | AER. Report number: 000308312. | All disclosed |
| A-2010-01113 | AER. Report number: 000308313. | All disclosed |
| A-2010-01114 | AER. Report number: 000308310. | All disclosed |
| A-2010-01115 | AER. Report number: 000308311. | All disclosed |
| A-2010-01116 | AER. Report number: 000308308. | All disclosed |
| A-2010-01118 | 88 page listing consisting of correspondences that were sent to the Minister's Office for signature. | Disclosed in part |
| A-2010-01122 | Records which demonstrate Dr. Cooney, Chief Dental Officer received consent in writing by Health Canada for each of the following contracts between Dr. Cooney and Public Health Units in Canada: 6 contracts for Thunder Bay Health Unit. (2007 to 2010). Contracts for the Northwestern Health Unit. (2007-2010). All other contracts for the Health Units in Canada. (2007-2011). |
Disclosed in part |
| A-2010-01132 | A list of all laboratory equipment, supplies and chemicals purchased by Health Canada in 2010. | All disclosed |
| A-2010-01137 | AER. Report number: 000349275. | Disclosed in part |
| A-2010-01144 | What are the outstanding First Nation communities that have boil water advisories across Canada. | All disclosed |
| A-2010-01175 | AERs for the product Celexa. Report numbers: 000341379, 000343451 and 000345911. | Disclosed in part |
| A-2010-01181 | List of all Question Period notes created for the Minister of Health Canada. (Dec 1, 2010 to Jan 24, 2011). | All disclosed |
| A-2010-01182 | Report of losses and thefts of meperidine. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01183 | Report of losses and thefts of Oxycodone. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01184 | Report of losses and thefts of morphine. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01185 | Report of losses and thefts of Oxycontin. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01186 | Report of losses and thefts of Fentanyl. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01187 | Report of losses and thefts of hydromorphone. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01188 | Report of losses and thefts of methadone. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01189 | Report of losses and thefts of buprenorphine. (Jan 1, 2010 to Dec 31, 2010). | All disclosed |
| A-2010-01201 | A copy of the document '2015 - Advancing Canada's Next generation of Health Care'. | All disclosed |
| A-2010-01202 | A copy of the document 'Federal Review of Progress: Electronic Health Records in Canada and the Role of Canada Health Infoway' and the 'Final Audit Report Audit of Transfer Payments to Canada Health Infoway inc May 2009'. | All disclosed |
| A-2010-01215 | Report listing for Supply Arrangements under TBIPS that have been generated in the National Capital Region. (Apr 1, 2010 to Oct 30, 2010). | All disclosed |
| A-2010-01216 | Requesting copies of Call ups from Temporary Help Services online issued by Departments for National Capital Region. For September and October 2010. | All disclosed |
| A-2010-01225 | AERs for the product Epival. Report numbers: 000342283 and 000344031. | Disclosed in part |
| A-2010-01226 | AERs for the product Humira. Report numbers: 000341553, 000342736, 000344360, 000345709 and 000346639. | Disclosed in part |
| A-2010-01229 | Copies of all reports of alleged theft of equipment or material. (Jan 1, 2010 to Feb 7, 2011). | Disclosed in part |
| A-2010-01230 | Listing of the ATI requests submitted to Health Canada for the period of January 1, 2011 to January 31, 2011. | Disclosed in part |
| A-2010-01231 | Listing of the ATI requests submitted to Health Canada for the period of December 1, 2010 to December 31, 2010. | Disclosed in part |
| A-2010-01232 | Number of SAP releases for Dacogen (Decitabine) for the month of January 2011. | All disclosed |
| A-2010-01233 | Number of SAP releases for Fotolyn (Pralatrexate) for the month of January 2011. | All disclosed |
| A-2010-01234 | Number of SAP releases for Prochymal (Remestemcel-L) for the month of January 2011. | All disclosed |
| A-2010-01235 | Number of SAP releases for Targretin (Bexaretene) for the month of January 2011. | All disclosed |
| A-2010-01236 | Number of SAP releases for Treanda (Bendamustine) for the month of January 2011. | All disclosed |
| A-2010-01237 | Number of SAP releases for Carfilzomib for the month of January 2011. | All disclosed |
| A-2010-01238 | Number of SAP releases for Cabazitaxel (Jevtana) for the month of January 2011. | All disclosed |
| A-2010-01240 | All documents concerning the Natural Health Products Regulations (NHPR) and the application and compliance measures taken by Health Canada inspectors. | All exempted |
| A-2010-01241 | All documents concerning the product Prostate Perform by New Roots Herbal Inc. | All exempted |
| A-2010-01245 | Information regarding the medical device Micro Driver Stent, Licence No. 69729 by Medtronic and the medical device Multi-Link Minivision Stent, Licence No. 62845 by Abbott. | All disclosed |
| A-2010-01251 | Temporary Help Call-ups. From June 2010 to November 2010. | Disclosed in part |
| A-2010-01254 | All call-ups issued under the terms of the TBIPS Standing Offer EN578-055605 in the National Capital Region during the month of January 2010. | All disclosed |
| A-2010-01255 | All National Capital Region Temporary Help Serives call-ups issued under the Supply Arrangement for the period of January 2010 to October 2010. | Disclosed in part |
| A-2010-01268 | Records of training sponsored by Health Canada provided to professional staff within the site licensing assessment division. (Feb 10, 2009 to Feb 9, 2011). | All disclosed |
| A-2010-01269 | All call-ups processed in the National Capital Region under the terms of the any Standing Offer and/or Supply Arrangement for Temporary Help Services during the period of January 2011. | Disclosed in part |
| A-2010-01273 | AER for the product Taxotere (docetaxel). Report number: 000360386. | Disclosed in part |
| A-2010-01282 | Any reports regarding the testing of the drinking water at the Attawapiskat First Nation. (Apr 1, 2008 to Mar 31, 2010). | Disclosed in part |
| A-2010-01288 | AERs for the product Iovate. Report numbers: 000341577, 000336640, 000340877, 000342447, 000344830, 000343071, 000335385, 000338881 and 000352531. | Disclosed in part |
| A-2010-01293 | Request for the actual awarded contract H380191691. | Disclosed in part |
| A-2010-01297 | All documents that pertain to food products from cloned animals. (Dec 1, 2007 to Feb 16, 2011). | Disclosed in part |
| A-2010-01300 | Copies of call ups for temp help for September, October, November, December 2010 and January 2011. | Disclosed in part |
| A-2010-01301 | All currently utilized policies and procedures related to the intake, processing and issuance of Authorizations to Possess Dried Marihuana, Personal Use Production Licenses and Designated-Person Production Licenses. | Disclosed in part |
| A-2010-01308 | AERs for the product Aleve. Report numbers: 000349064 and 000351971. | Disclosed in part |
| A-2010-01309 | AER for the product One A Day. Report number: 000348467. | Disclosed in part |
| A-2010-01310 | AER for the product Canesten. Report number: 000351112. | Disclosed in part |
| A-2010-01320 | Information regarding the Diacol tablets, and oral sodium phosphate product used for bowel cleansing prior to colonoscopy. Paladin Labs is believed to have requested approval for Diacol from Health Canada during the time period of 2003 to 2008. | All exempted |
| A-2010-01329 | All documentation submitted to support the licensing of the natural health products, Juice Plus+ Garden Blend (EN-111587) and Juice Plus+ Orchard Blend (EN-111607) from NSA, LLC. | All exempted |
| A-2010-01338 | AERs for the product CIPRO XL. Report numbers: 000355983 and 000356192. | Disclosed in part |
| A-2010-01339 | AER for the product LEVITRA. Report number: 000355874. | Disclosed in part |
| A-2010-01340 | AER for the product MIRENA. Report number: 000354712. | Disclosed in part |
| A-2010-01341 | AER for the product NEXAVAR. Report number: 000356183. | Disclosed in part |
| A-2010-01342 | AERs for the product XARELTO. Report numbers: 000355150 and 000355967. | Disclosed in part |
| A-2010-01343 | AERs for the product YAZ. Report numbers: 000354628, 000355166 and 000355454. | Disclosed in part |
| A-2010-01386 | The CCRPB states that the level of SPF obtained or developed by a sun bed is between 2-4 SPF. Requesting the source of this document. | All disclosed |
| A-2010-01387 | AERs for the product Lupron. Report numbers: 000342627 and 000343746. | Disclosed in part |
| A-2010-01391 | A copy of the application for approval of propentofylline to treat Alzheimer disease. | All exempted |
| A-2010-01401 | All trihalomethane test results of water samples taken in Fort McKay (also spelled Fort MacKay) and Fort Chipewyan (both in Alberta). (Jan 1, 2006 to Feb 24, 2011). | All disclosed |
| A-2010-01403 | Information regarding the importations/exportations, per quarter, for the sales of: Cigar (In sticks), Snuff (in Kilo), Chewing Tobacco (in Kilo) and Pipe Tobacco (in Kilo), cigarettes (in sticks, roll your own tobacco (in Kilo)). (Jan 1, 2000 to Mar 31, 2011). | All disclosed |
| A-2010-01423 | Number of SAP releases for Dacogen (Decitabine) for the month of February 2011. | All disclosed |
| A-2010-01424 | Number of SAP releases for Fotolyn (Pralatrexate) for the month of February 2011. | All disclosed |
| A-2010-01425 | Number of SAP releases for Prochymal (Remestemcel-L) for the month of February 2011. | All disclosed |
| A-2010-01426 | Number of SAP releases for Targretin (Bexaretene) for the month of February 2011. | All disclosed |
| A-2010-01427 | Number of SAP releases for Treanda (Bendamustine) for the month of February 2011. | All disclosed |
| A-2010-01428 | Number of SAP releases for Carfilzomib for the month of February 2011. | All disclosed |
| A-2010-01429 | Number of SAP releases for Cabazitaxel (Jevtana) for the month of February 2011. | All disclosed |
| A-2010-01457 | All 2008 records on the strategies developed and their costs as they relate to reviewing the data on the health risks and other factors associated with chrysolite asbestos. | Disclosed in part |
| A-2010-01461 | Documentation which indicates all appointments term and casual employees in the National Capital Region during February 2011. | All disclosed |
| A-2010-01462 | All callups issued under the terms of the TBIPS Standing Offer (EN578-055605 in the National Capital Region during the month of February 2011. | Disclosed in part |
| A-2010-01463 | All Callups processed in the National Capital Region under the terms of any standing offer and/or supply arrangement for Temporary Help Services during February 2011. | Disclosed in part |
| A-2010-01466 | AER. Report number: 000346376. | Disclosed in part |
| A-2010-01467 | AER. Report number: 000334437. | Disclosed in part |
| A-2010-01468 | AER. Report number: 000333765. | Disclosed in part |
| A-2010-01469 | AER. Report number: 000331548. | Disclosed in part |
| A-2010-01470 | AER. Report number: 000339765. | Disclosed in part |
| A-2010-01471 | AER. Report number: 000338887. | Disclosed in part |
| A-2010-01472 | AER. Report number: 000338555. | Disclosed in part |
| A-2010-01473 | AER. Report number: 000342122. | Disclosed in part |
| A-2010-01499 | Previously released request A-2006-00417: All documents on the illegal sale of cigarettes to young minors in Quebec from January 1, 2005 to June 24, 2006. | Disclosed in part |
| A-2010-01500 | Previously released request A-2005-01601: All documents concerning number of Canadian establishments caught selling cigarettes to minors. (From Apr 1, 2000 to Mar 31, 2001 and Mar 1, 2005 to Mar 13, 2006) | Disclosed in part |
| A-2010-01501 | Previously released request A-2006-00415: All documents on the illegal sale of cigarettes and tobacco to minors throughout Quebec from January 1, 2005 to June 24, 2006. | Disclosed in part |
| A-2010-01502 | Previously released request A-2006-00418: All documents on the illegal sale of cigarettes and tobacco on Indian reserves in Quebec for the past 36 months to date (June 24, 2006). | Disclosed in part |
| A-2010-01503 | Previously released request A-2007-00026: The original (1992) Master Agreement between Health Canada and St. Mary's First Nation. Signed copies of all annual progress activity reports and for the activities associated with the expenditure of all surplus dollars (2003, 2004, 2005, 2006, and 2007). | Disclosed in part |
| A-2010-01565 | Previously released request A-2009-01155: All Question Period Notes for: - 2009-05-25: French Language Services at Canadian Blood Service in New Brunswick, H1N1 Flu Virus, Hepatitis C Compensation (Pre-1986/Post-1990) - Timing of Payments, HIV/AIDS - Mother-to-child Transmission of HIV, Medical Marihuana. - 2009-05-26 - H1N1 Flu Virus, Patient Safety - Medical Errors. - 2009-05-27 - H1N1 Flu Virus. - 2009-05-28 - Breast Cancer Testing, Direct to Consumer Advertising (DTCA). - 2009-05-29 - Supply of Medical Isotopes. - 2009-06-01 - Marihuana Medical Access Program - Response to Court Decisions. - 2009-06-19 - Food Safety - Listeria probe to call for public inquiry - Committee to Request Overhaul of Public Health Agency, The Release of Radioactivity From Reactor At Chalk River Laboratories. |
Disclosed in part |
| A-2010-01587 | Previously released request A-2005-01141: All correspondence received by the ministry from other government departments regarding planning for an influenza pandemic. (Jul 1, 2005 to Nov 28, 2005). | Disclosed in part |
| A-2010-01588 | Previously released request A-2006-01333: All documents relating to reporting compliance pursuant to S.13 of the Canada Health Act by the government of Saskatchewan from 1995-present (Mar 6, 2007). | All disclosed |
| A-2010-01589 | Previously released request A-2007-00099: All documents recommending that exposure to pesticides be reduced. (Jan 1, 2003 to Apr 25, 2007). | All disclosed |
| A-2010-01590 | Previously released request A-2010-00098: A list of all incidents suspected of contravening the Canada Health Act. (Jan 1, 2008 to Apr 23, 2010). | All disclosed |
